Original-Research: Nynomic AG (von NuWays AG): BUY
|
Original-Research: Nynomic AG - from NuWays AG
Classification of NuWays AG to Nynomic AG
Weak Q2 amid restructuring expenses and weak demand; PT down Q2 EBIT came in at € -1.1m (H1: € -2.0m), compared with € 2.6m in Q2 2024 (H1 2024: €4.2m). This deterioration was driven by lower revenues, reduced production utilization, an unfavorable product mix and restructuring expenses of roughly €1.5m recognized in H1 under the NyFIT2025 program. FY25 forecast adjusted. Management reduced it FY25 guidance from € 105-110m revenue and €8.5-10.0m EBIT to € 100-105m revenue (eNuW old: € 108m) and € 2.0-4.0m EBIT (eNuW old: € 9.1m). The downgrade reflects slower-than-expected order normalization, delayed project awards, and the temporary EBIT drag from restructuring. Despite this, management anticipates a sequential improvement in H2, with Q4 expected to be the strongest quarter of the year, similar to recent years. Efficiency program “NyFIT2025” formally introduced. Internally launched in late 2024, NyFIT2025 targets € 5-6m in annual cost savings from 2026 onwards (eNuW: € 5m). Measures include workforce adjustments (number of employees was down 5% at the end of H1), optimization of internal processes, and structural consolidation; notably, merging Spectral Engines GmbH into m-u-t GmbH to simplify operations. The majority of the related upfront costs were already booked during H1 (~ € 1.5m). Going forward, management expects enhanced productivity, improved flexibility, and a leaner fixed cost base, better aligning the company to a volatile demand environment. We are reducing our price target to € 24.5 (old: € 34.5) accounting for the temporary subdued demand situation across key end markets but reiterate our BUY recommendation as the prospects during the mid-term remain bright. Once notable sales volumes return, one should expect an overproportionate impact on margins supported by the current right-sizing of operations. You can download the research here: nynomic-ag-2025-08-14-previewreview-en-8609c For additional information visit our website: https://www.nuways-ag.com/research-feed Contact for questions: NuWays AG - Equity Research Web: www.nuways-ag.com Email: research@nuways-ag.com LinkedIn: https://www.linkedin.com/company/nuwaysag Adresse: Mittelweg 16-17, 20148 Hamburg, Germany ++++++++++ Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte. Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse. ++++++++++
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
||||||||||||||||||||
2183802 14.08.2025 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 64,86 | 78,56 | 105,08 | 116,79 | 117,99 | 102,42 | 102,50 | |
| EBITDA1,2 | 9,55 | 11,43 | 17,00 | 19,18 | 20,22 | 15,51 | 7,00 | |
| EBITDA-Margin3 | 14,72 | 14,55 | 16,18 | 16,42 | 17,14 | 15,14 | 6,83 | |
| EBIT1,4 | 6,43 | 7,97 | 12,99 | 15,08 | 15,43 | 7,39 | 2,00 | |
| EBIT-Margin5 | 9,91 | 10,15 | 12,36 | 12,91 | 13,08 | 7,22 | 1,95 | |
| Net Profit (Loss)1 | 4,30 | 5,18 | 9,52 | 9,95 | 10,53 | -0,27 | -0,15 | |
| Net-Margin6 | 6,63 | 6,59 | 9,06 | 8,52 | 8,92 | -0,26 | -0,15 | |
| Cashflow1,7 | 3,56 | 6,37 | 17,83 | 9,68 | 3,17 | 7,79 | 6,80 | |
| Earnings per share8 | 0,87 | 0,83 | 1,37 | 1,26 | 1,47 | -0,10 | -0,02 | |
| Dividend per share8 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Dr. Clauß, Dr. Paal & Partner
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Nynomic | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A0MSN1 | DE000A0MSN11 | AG | 72,45 Mio € | 02.07.2007 | Halten | 9F5FHPV5+7C |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 15,71 | 22,93 | 0,69 | 10,97 | 0,74 | 9,29 | 0,71 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 0,00 | 0,00 | 0,00% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 08.07.2025 | 08.05.2025 | 12.08.2025 | 28.11.2025 | 22.05.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +2,52% | -12,13% | -37,50% | -37,85% | +7,32% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.